Kawachi, Hayato
Fujimoto, Daichi http://orcid.org/0000-0003-0615-3000
Morimoto, Takeshi
Hosoya, Kazutaka
Sato, Yuki
Kogo, Mariko
Nagata, Kazuma
Nakagawa, Atsushi
Tachikawa, Ryo
Tomii, Keisuke
Article History
Received: 18 February 2019
Accepted: 25 March 2019
First Online: 1 April 2019
Compliance with ethical standards
:
: Dr. Kawachi has received lecture fees from Ono Pharmaceutical Co., Ltd., Chugai Pharmaceutical, Merck Sharp and Dohme, and Taiho Pharmaceutical. Dr. Fujimoto has received lecture fees from Ono Pharmaceutical Co., Ltd., Bristol-Myers Squibb K.K., Chugai Pharmaceutical, AstraZeneca, Merck Sharp and Dohme, and Taiho Pharmaceutical. Dr. Hosoya has received lecture fees from Chugai Pharmaceutical, Merck Sharp and Dohme, and Taiho Pharmaceutical. Dr. Sato has received lecture fees from Ono Pharmaceutical Co., Ltd. Dr. Tomii has received lecture fees from Chugai Pharmaceutical, AstraZeneca, and Taiho Pharmaceutical. The remaining authors have declared that they have no conflicts of interest.
: All study procedures complied with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments.